BR9508927A - Processo para a preparação de compostos e composto - Google Patents
Processo para a preparação de compostos e compostoInfo
- Publication number
- BR9508927A BR9508927A BR9508927A BR9508927A BR9508927A BR 9508927 A BR9508927 A BR 9508927A BR 9508927 A BR9508927 A BR 9508927A BR 9508927 A BR9508927 A BR 9508927A BR 9508927 A BR9508927 A BR 9508927A
- Authority
- BR
- Brazil
- Prior art keywords
- compost
- compounds
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/307,972 US5585504A (en) | 1994-09-16 | 1994-09-16 | Process of making cox-2 inhibitors having a lactone bridge |
PCT/US1995/011539 WO1996008482A1 (en) | 1994-09-16 | 1995-09-12 | Process for making phenyl heterocycles useful as cox-2 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9508927A true BR9508927A (pt) | 1997-12-30 |
Family
ID=23191976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9508927A BR9508927A (pt) | 1994-09-16 | 1995-09-12 | Processo para a preparação de compostos e composto |
Country Status (12)
Country | Link |
---|---|
US (1) | US5585504A (pt) |
CN (1) | CN1065533C (pt) |
AU (1) | AU3510595A (pt) |
BR (1) | BR9508927A (pt) |
CZ (1) | CZ288797B6 (pt) |
FI (1) | FI106376B (pt) |
RO (1) | RO118585B1 (pt) |
RU (1) | RU2160257C2 (pt) |
SK (1) | SK282789B6 (pt) |
TW (1) | TW325468B (pt) |
UA (1) | UA49809C2 (pt) |
WO (1) | WO1996008482A1 (pt) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807873A (en) * | 1996-04-04 | 1998-09-15 | Laboratories Upsa | Diarylmethylidenefuran derivatives and their uses in therapeutics |
FR2747123B1 (fr) * | 1996-04-04 | 1998-06-26 | Union Pharma Scient Appl | Nouveaux derives diarylmethylidene tetrahydrofurane, leurs procedes de preparation, et leurs utilisations en therapeutique |
US6180651B1 (en) * | 1996-04-04 | 2001-01-30 | Bristol-Myers Squibb | Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
US5883267A (en) * | 1996-05-31 | 1999-03-16 | Merck & Co., Inc. | Process for making phenyl heterocycles useful as cox-2 inhibitors |
HRP970289A2 (en) * | 1996-05-31 | 1998-04-30 | Merck & Co Inc | Process for preparing phenyl heterocycles useful as cox-2 inhibitors |
US5985930A (en) * | 1996-11-21 | 1999-11-16 | Pasinetti; Giulio M. | Treatment of neurodegenerative conditions with nimesulide |
WO1998037235A1 (en) | 1997-02-24 | 1998-08-27 | Cornell Research Foundation, Inc. | Method of screening agents as candidates for drugs or sources of drugs |
DE69816047T2 (de) * | 1997-03-14 | 2004-04-22 | Merck Frosst Canada & Co, Kirkland | (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer |
US6071954A (en) * | 1997-03-14 | 2000-06-06 | Merk Frosst Canada, Inc. | (methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2 inhibitors |
US6294558B1 (en) * | 1999-05-31 | 2001-09-25 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
US6727238B2 (en) * | 1998-06-11 | 2004-04-27 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
TNSN99111A1 (fr) * | 1998-06-11 | 2005-11-10 | Pfizer | Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. |
DE60023119T2 (de) * | 1999-03-10 | 2006-07-20 | G.D. Searle Llc | Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere |
US6506779B1 (en) | 1999-12-03 | 2003-01-14 | Pfizer Inc. | Acetylene derivatives as anti-inflammatory/analgesic agents |
EP1104759B1 (en) | 1999-12-03 | 2003-10-22 | Pfizer Products Inc. | Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
ES2193921T3 (es) | 1999-12-03 | 2003-11-16 | Pfizer Prod Inc | Compuestos de sulfamoilheteroaril-pirazol como agentes antinflamatorios/analgesicos. |
OA12100A (en) | 1999-12-03 | 2006-05-04 | Pfizer Prod Inc | Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents. |
MXPA01008058A (es) | 1999-12-08 | 2004-04-05 | Pharmacia Corp | Composiciones deinhibidor de cicloxigenasa-2 teniendo un rapido inicio de efecto terapeutico. |
DE10012825B4 (de) | 2000-03-16 | 2004-04-15 | Bayer Corp. | Verfahren zur Herstellung von spirocyclischen Tetronsäurederivaten |
CN1102586C (zh) * | 2000-04-07 | 2003-03-05 | 中国科学院上海有机化学研究所 | β位含有芳基取代基的γ-丁烯酸内酯及其固相合成法 |
WO2002005848A2 (en) * | 2000-07-13 | 2002-01-24 | Pharmacia Corporation | Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
AU2001285334A1 (en) * | 2000-08-29 | 2002-03-13 | Peter Van Patten | Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid |
US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
PE20021017A1 (es) | 2001-04-03 | 2002-11-24 | Pharmacia Corp | Composicion parenteral reconstituible |
DE60204823T2 (de) | 2001-07-05 | 2005-12-29 | Pfizer Products Inc., Groton | Heterocyclo-alkylsulfonyl Pyrazole als entzündungshemmende/analgetische Mittel |
UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
GT200200183A (es) | 2001-09-28 | 2003-05-23 | Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol | |
WO2003037336A1 (en) | 2001-11-02 | 2003-05-08 | Pfizer Products Inc. | 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer |
ES2213485B1 (es) | 2003-02-13 | 2005-12-16 | Almirall Prodesfarma, S.A. | Derivados de la 2-fenilpiran-4-ona. |
ES2275218T3 (es) * | 2003-05-07 | 2007-06-01 | Osteologix A/S | Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos. |
DK1622630T3 (da) * | 2003-05-07 | 2012-12-17 | Osteologix As | P009368epdk1 |
WO2005016906A1 (en) * | 2003-08-14 | 2005-02-24 | Shasun Chemicals And Drugs Limited | Process for the manufacture of rofecoxib |
WO2005044227A1 (en) * | 2003-11-05 | 2005-05-19 | Glenmark Pharmaceuticals Limited | Topical pharmaceutical compositions |
US20050100594A1 (en) * | 2003-11-12 | 2005-05-12 | Nilendu Sen | Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor |
CN113660934A (zh) | 2018-11-21 | 2021-11-16 | 特默罗制药股份有限公司 | 罗非昔布的纯化形式、制备方法和用途 |
US10945992B1 (en) | 2019-11-13 | 2021-03-16 | Tremeau Pharmaceuticals, Inc. | Dosage forms of rofecoxib and related methods |
US11161833B1 (en) | 2021-04-09 | 2021-11-02 | Tremeau Pharmaceuticals, Inc. | Deuterated etoricoxib, methods of manufacture, and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994015932A1 (en) * | 1993-01-15 | 1994-07-21 | G.D. Searle & Co. | Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
US5462939A (en) * | 1993-05-07 | 1995-10-31 | Sterling Winthrop Inc. | Peptidic ketones as interleukin-1β-converting enzyme inhibitors |
HUT74986A (en) * | 1994-01-10 | 1997-03-28 | Merck Frosst Canada Inc | Phenyl heterocycles as cox-2 inhibitors, pharmaceutical preparations containing them, and use of them |
-
1994
- 1994-09-16 US US08/307,972 patent/US5585504A/en not_active Expired - Fee Related
-
1995
- 1995-09-08 TW TW084109387A patent/TW325468B/zh active
- 1995-09-12 CN CN95195075A patent/CN1065533C/zh not_active Expired - Fee Related
- 1995-09-12 RU RU97106093/04A patent/RU2160257C2/ru not_active IP Right Cessation
- 1995-09-12 CZ CZ1997792A patent/CZ288797B6/cs not_active IP Right Cessation
- 1995-09-12 SK SK316-97A patent/SK282789B6/sk unknown
- 1995-09-12 BR BR9508927A patent/BR9508927A/pt not_active Application Discontinuation
- 1995-09-12 UA UA97041788A patent/UA49809C2/uk unknown
- 1995-09-12 WO PCT/US1995/011539 patent/WO1996008482A1/en active Search and Examination
- 1995-09-12 AU AU35105/95A patent/AU3510595A/en not_active Abandoned
- 1995-09-12 RO RO97-00484A patent/RO118585B1/ro unknown
-
1997
- 1997-03-14 FI FI971104A patent/FI106376B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW325468B (en) | 1998-01-21 |
CZ288797B6 (cs) | 2001-09-12 |
WO1996008482A1 (en) | 1996-03-21 |
UA49809C2 (uk) | 2002-10-15 |
CN1159191A (zh) | 1997-09-10 |
US5585504A (en) | 1996-12-17 |
RO118585B1 (ro) | 2003-07-30 |
RU2160257C2 (ru) | 2000-12-10 |
CN1065533C (zh) | 2001-05-09 |
FI106376B (fi) | 2001-01-31 |
FI971104A0 (fi) | 1997-03-14 |
CZ79297A3 (en) | 1997-07-16 |
SK282789B6 (sk) | 2002-12-03 |
FI971104A (fi) | 1997-03-14 |
SK31697A3 (en) | 1997-10-08 |
AU3510595A (en) | 1996-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9508927A (pt) | Processo para a preparação de compostos e composto | |
PT1256584E (pt) | Processo para a preparacao de adefovir-dipivoxil | |
BR9505754A (pt) | Processo para a preparação de copolímeros de poliéster | |
BR9710457A (pt) | Processo para a prepara-Æo de ciclohexanodimetanol | |
PT770615E (pt) | Processo para a preparacao de di-haloazolopirimidinas | |
BR9710104A (pt) | Processo para a preparação de particulas políméricas | |
BR9510336A (pt) | Processo para a síntese de polímeros composição e polímero | |
BR9404206A (pt) | Processo para a preparação de um composto indanil-amina compostos intermediários e processo para a preparação de compostos intermediários | |
BR9711201A (pt) | Processo para a prepara-ao de um composto | |
BR9500668A (pt) | Processo para a preparaçao de compostos polialquil-1-oxa- diazaspirodecano | |
BR9508320A (pt) | Processo para a preparação de um composto e cultura biologicamente | |
PT900254E (pt) | Processo para a preparacao de composicoes de betume | |
BR9707811A (pt) | Processo para preparação de um composto e composto | |
BR9301180A (pt) | Processo para a preparacao de isocianatos e emprego | |
BR9500613A (pt) | Processo para a preparação contínua de mononitrotoluenos | |
BR9400604A (pt) | Processo para a preparação de 1,1,1,3,3-pentafluorpropano | |
BR9505251A (pt) | Processo para a fabricação de um composto e composto obtido | |
BR9702047A (pt) | Processo para a preparação de uréia granular | |
PT880498E (pt) | Processo para a preparacao de compostos dicetonicos | |
BR9606204A (pt) | Processo para a preparação de pentaeritritol | |
BR9301676A (pt) | Processo para a preparacao de 1,1,1,4,4,4-hexafluorbutano e compostos obtidos | |
PT803576E (pt) | Processo para a preparacao de lipstatina e de tetra-hidrolipstatina | |
BR9201995A (pt) | Processo para obtencao de adubo | |
BR9711994A (pt) | Compostos de beta-lactama e processo para a prepara-Æo dos mesmos | |
PT1012152E (pt) | Processo para a preparacao de oxazafosforina-2-aminas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |